Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer

Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer

US Patent 12077534 · Granted Sep 3, 2024

Estimated economic value: $1,045,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutically active compounds and their methods of use2025
Pyruvate kinase activators for use in treating blood disorders2024
Bicyclic heteroaryl substituted compounds2024
Biarylmethyl heterocycles2024
Inhibitors of cellular metabolic processes2024
Inhibitors of cellular metabolic processes2024
Pyruvate kinase activators for use in treating blood disorders2024
Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 in2024
Compounds and methods useful for stabilizing phenylalanine hydroxylase mutations2024
Pyruvate kinase modulators and use thereof2024
Therapeutically active compounds and their methods of use2023
Pyruvate kinase activators for use in treating blood disorders2023